TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
130 hedge funds and large institutions have $360M invested in Tvardi Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+9
Holders Change %
+7.44%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
27
Increased
37
Reduced
32
Closed
18
Calls
$21.7M
Puts
$19.5M
Net Calls
+$2.22M
Net Calls Change
+$5.55M
Top Buyers
1 |
CG
Carmignac Gestion
Paris,
France
|
+$11.6M |
2 |
First Manhattan
New York
|
+$7.18M |
3 |
![]()
Marshall Wace
London,
United Kingdom
|
+$6.68M |
4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.75M |
5 |
Goldman Sachs
New York
|
+$3.48M |